EPCLUSA

gilead sciences canada inc🇨🇦 Health Canada

Approval Id: 01a0cf499928e8bf
Drug Approval Canada Name: EPCLUSA
Product Name: EPCLUSA
Status: Marketed
Status Date: 2016-08-02
Original Market Date: 2016-08-02
Din: 02456370
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.40.24
Atc Original: J05AP55 SOFOSBUVIR AND VELPATASVIR
Atc Name: j 05 ap 55
Aig Number: 0258270001
Company Name: gilead sciences canada inc
Company Address: 400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2

SOFOSBUVIR

400 MG

VELPATASVIR

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

01a0cf499928e8bf

Type

Standard